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Letter to the Editor
The multiple sleep latency test and Epworth sleepiness scale in the assessment
of daytime sleepiness
Dr Murray Johns' recent article argues that the Epworth
Sleepiness Scale (ESS) not only costs about 1000 times less
than the Multiple Sleep Latency Test (MSLT) but also
serves as a superior gold standard measure of excessive
daytime sleepiness (Johns, 2000). The article provides no
new data but relies on published ESS and MSLT results
from normal and narcoleptic subjects to calculate sensitiv-
ities and speci®cities of the ESS and MSLT for these states,
which are assumed to represent fully alert and pathologically
sleepy individuals. Receiver-operator curves then show that
the ESS assigns subjects to their correct groups with nearly
perfect accuracy, whereas the MSLT does not perform as
well.
Unfortunately, these analyses are ¯awed. The narcoleptics
were de®ned, in large part, by their subjective complaint of
excessive daytime sleepiness (American Sleep Disorders
Association 1997; Mitler et al. 1998; US Moda®nil in Nar-
colepsy Multicentre Study Group 1998). The normal subjects'
MSLT data were derived from a study in which no subject
with subjective daytime sleepiness could be included (Levine
et al. 1988). Normal subjects' ESS data (Johns and Hocking
1997) were taken from the 72 (22%) of 331 Australians who
were, as described by Johns, `selected by strict criteria derived
from a detailed sleep questionnaire' (Johns 2000); this sample,
de®ned by self-report, could be labeled `super subjective
normals'.
The result is that in John's re-analysis, the normal subjects
had no subjective sleepiness and the narcoleptics did have
subjective sleepiness, by de®nition. Subjects were grouped
more by virtue of their subjective sleepiness than by objective
criteria. Johns then showed that the subjectively derived ESS
assigned persons to their subjectively de®ned groups more
accurately than did the objective MSLT. The ESS previously
has been shown to correlate well with patients' own percep-
tions of their sleepiness, and to have weak or no correlation
with objective measures of sleepiness (Chervin and Aldrich
1999): Johns' recent analysis only seems to con®rm these
observations.
Several additional problems with the ESS are not addressed
in Johns' article. Increasing evidence suggests that in the
assessment of sleepiness, the ESS is subject to undesirable
confounding variables, including gender (Chervin and Aldrich
1999), psychological in¯uences (Olson et al. 1998), and
subjective perception of fatigue, tiredness, and lack of energy
(Chervin, 2000a). Although Johns repeatedly argues, based on
face validity, that the ESS measures sleep propensity in eight
speci®c situations rather than just one (like the MSLT) (Johns
1991, Johns 1993; Johns 1994; Johns 1998; Johns 2000) he has
provided no criterion validity to substantiate this argument. In
one study that did test his hypothesis, subjective responses to
the ESS item that asks about `lying down to rest in the
afternoon when circumstances permit' failed to show any
robust association with objective measures in this speci®c
situation, namely the afternoon naps of MSLTs (Chervin et al.
1997).
Finally, Johns' recent article was somewhat selective in its
review of existing literature. The largest existing studies of
sleep apneics assessed with both MSLTs and Epworth scales
showed no statistically signi®cant associations between the
two measures (Chervin and Aldrich 1999; Benbadis et al.
1999). Some studies suggest that apnea severity as determined
by polysomnography is associated with MSLT-measured
sleepiness but not with ESS scores (Chervin et al. 1997;
Chervin and Aldrich 1999; Kingshott et al. 1995). A recent
study of 1824 individuals did show a highly signi®cant ± but
impressively weak ± association between apnea severity and
ESS scores (Gottlieb et al. 1999). For example, the subjects
with little or no sleep apnea had a mean ESS score of
7.2  4.3 while those with the most severe apnea had a mean
score of 9.3  4.9.
Johns is correct in writing that the MSLT is unlikely to be
a perfect gold standard, but in that respect the test is similar
to many other medical gold standards. His point is also well
taken that the 5 and 10 minute `rule of thumb' for MSLT
interpretation should not be misused. Strict cut-points on a
continuous unimodal measure will almost always serve a
patient poorly if results are not carefully integrated and
weighed with data derived from the patient's medical history
(Chervin, 2000b). Neither the MSLT nor the ESS have been
well-validated against objective sleepiness-related outcomes of
importance to patients, such as motor vehicle crashes or work
performance. Until those important data become available,
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an ESS may indeed cost 1000 times less than an MSLT, but
those who seek this savings may end up getting what they
paid for.
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Ann Arbor, Michigan, U.S.A.
Reply
I welcome the opportunity to respond to the above letter of
Dr Chervin about my paper, `Sensitivity and speci®city of the
multiple sleep latency test (MSLT), the maintenance of
wakefulness test and the Epworth sleepiness scale: Failure of
the MSLT as a gold standard' (Johns 2000). In this paper I
reported evidence, based on receiver operator characteristic
curves, that the ESS is more accurate than either the MSLT or
the MWT in distinguishing normal from abnormal daytime
sleepiness in the sense of a subject's sleep propensity in daily
life.
Dr Chervin claims that the groups of narcoleptics and
normal subjects used in my assessment of the sensitivity and
speci®city of the ESS were selected mainly on the basis of their
levels of `subjective sleepiness', which is what he thinks the ESS
measures. He argues therefore that for me to use the ESS as a
measure of `subjective sleepiness' to distinguish groups of
subjects who were selected because they dier in that regard, is
not a valid test of the ESS. Of course, he would be right if his
assumptions were valid, but they are not.
Dr Chervin fails to distinguish `subjective sleepiness' from
sleep propensity, which is what the MSLT and MWT measure
objectively and the ESS measures subjectively. He confuses the
method of measurement with the nature of what is to be
measured. I believe `subjective sleepiness' refers to the
presence/absence or the intensity of a set of feelings and
symptoms that accompany the drowsy state, measured, for
example, by the Karolinska sleepiness scale. This is not what
the ESS measures (Johns 1998). Use of the term `sleepiness' to
mean any of several dierent things is, in my opinion, a cause
of much of the present confusion in this ®eld. Dr Chervin is
also wrong in his claim that my control subjects, who provided
normal ESS scores, were selected on the basis of an absence of
complaints about `subjective sleepiness'. In fact, they were
selected, post hoc, solely on the basis of their reported sleep
characteristics, without reference to their sleepiness, as follows:
their usual sleep quality was `good' or `very good'; they did not
snore or snored only occasionally; they were not reported to
stop breathing or to make choking noises during sleep; they
seldom had diculty in falling asleep initially and usually took
less than 30 min to do so; they did not recall being awake more
than twice per night, if at all, and did not have diculty going
back to sleep. The mean duration of their usual sleep period
(which was not a selection criterion) was 7 h 37  54 min
(SD), with a range in dierent subjects from 5 h 25 min to 11 h
30 min (Johns and Hocking 1997). Quite what Dr Chervin
means when he calls these subjects `super subjective normal' I
do not know.
The above criticism may be more appropriately directed at
the validity of the equivalent MSLT results because the
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